PARP1/2 inhibitor; binds within the nicotinamide-binding pocket in the ADP-ribosyl transferase catalytic site, contacting with the regulatory subdomains; traps PARP to DNA damage sites;Talazoparib is effective in both BRCAMut and PTENMut cancer cells. This evidence concerns the gene PARP1 and cancer.